Clinical Trial Update: A Study of MabThera/Rituxan (Rituximab) in Combination With Methotrexate in Patients With Rheumatoid Arthritis and Inadequate Response to DMARD Therapy [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update of Rituximab in combination with methotrexate in rheumatoid arthritis patients with inadequate response to DMARDs. The study has c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• METHOTREXATE (METHOTREXATE)
• Rituximab (MabThera / Rituxan) (rituximab)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Rheumatoid Arthritis | Phase 3 | Status: COMPLETED | Results posted: 2014-11-06